Article
Chemo-sEVs release in cisplatin-resistance ovarian cancer cells are regulated by the lysosomal function
2023-02-04
Abstract excerpt
<h4>ABSTRACT</h4> Ovarian cancer (OvCa) is an aggressive disease usually treated with cisplatin (CDDP)-based therapy. However, among the different types of cancers treated with CDDP, OvCa commonly develops chemoresistance to this treatment. The small extracellular vesicles (sEVs) play a central role in chemoresistance. In response to chemotherapy, resistant cells secrete sEVs named chemo-sEVs characterized by spe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f44d8412-0bfe-51b9-929f-da3a5715657b
- DOI
- 10.1101/2023.02.03.526974
